Polyclonal antibodies are produced when different B-cell clones in the immune system respond to the same antigen. It produces a variety of antibodies that can bind to different sites on that antigen.
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
The Pharmaceuticals and Medical Devices Agency (PMDA) published guidance on using a weight of evidence (WOE) approach to ...
Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...
CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...
Since its inception in 1975, hybridoma technology has revolutionized the way researchers produce antibodies in vitro. In this article, learn about the steps involved in creating a hybridoma, hybridoma ...
Antibodies are one of the most specific tools for the detection and capture of molecular targets. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results